Livzon Syntpharm Co., Ltd.

Livzon Syntpharm Co., Ltd.

Livzon Syntpharm Co., Ltd. is a subsidiary of Livzon Pharmaceutical Group Inc. It was established in 1993 with an initial investment of RMB 500 million and occupies 100,000 square meters of land. The current staff is 500 persons. It is a leading API manufacturer in China, focused on the R&D and manufacture of cephalosporins. The main products include ceftriaxone sodium, cefuroxime sodium, cefodizime sodium, ilaprazole, and ligustrazine phosphate. The production capacity of ceftriaxone is the highest among Chinese manufacturers. The company has been honored with the Technologically Advanced Enterprise and High-Tech Enterprise in Guangdong Province awards.